Skip to content
Blerp – Lifestyle
Author:
VANDA PHARMACEUTICALS INC
NEREUS™ – The Goat of Biscayne Bay Arrives for Miami Art Week
November 11, 2026
Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences
November 3, 2026
Vanda Pharmaceuticals Reports Third Quarter 2026 Financial Results
October 28, 2026
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
October 27, 2026
Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
October 21, 2026
Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
October 14, 2026
Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting
October 2, 2026
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
September 29, 2026
Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences
September 2, 2026
Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 5, 2026
1
2
Next Page
→